Testsealabs high accuracy IBR Infectious Rhinitis Antibody Test

Name: Testsealabs high accuracy IBR Infectious Rhinitis Antibody Test
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 2230598755

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$1.70

100-799 Pieces

US$1.50

800-1,599 Pieces

US$1.30

1,600+ Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Varieties

Veterinary Test Kit

Component

Veterinary Test Kit

Model NO.

108922

Type

Veterinary Test Kit

Pharmacodynamic Influential Factors

Veterinary Test Kit

Storage Method

Veterinary Test Kit

Veterinary Reg. No.

Product Name

IBR Ab Rapid Test

Application

Veterinary Test Kit

MOQ

100PCS

OEM/ODM

Available

Specimen

Feces

Shelf Life

24 Months

Storage

4-30°c

Time

10-15 Mins

Package Specification

10PCS/Box or 20PCS/Box;

Accuracy

Over 96%

Feature

Easy to Operate, No Equipment Needed;

Seller

Factory

Brand

Testsealabs

Transport Package

Box

Specification

10/20 Tests/Box

Trademark

Testsealabs

Origin

China

Production Capacity

5000000PC Per Month

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤10.15h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology is identified as a China-based limited company in Hangzhou, with records describing it as both a trading company and manufacturer/factory. Its stated capabilities include in-vitro diagnostic, veterinary, rapid-test, reagent, and medical-machine products. The supplier reports ISO 9001 and GMP certification, more than 10 production lines, 50 R&D engineers, 50 quality-control staff, and exports to multiple global regions. It describes three technical platforms and sales coverage exceeding 100 countries and regions. However, the evidence does not establish after-sales performance, financial credibility, or product-customization capability. One record associates the supplier with a 2025 THC urine-test product and a Vietnamese buyer, but this is limited customer evidence and does not independently verify broader performance.

Supplier typeThe supplier is identified as a limited company headquartered in Hangzhou, China, and is described as both a trading company/manufacturer-factory. A separate record characterizes the company nature as a factory, supporting a manufacturing role alongside trading activity.

CertificationsThe supplier reports ISO 9001 and GMP certification under its management-system certifications. These are explicit certifications relevant to quality and manufacturing controls.

R&D capabilityThe supplier states that it develops core innovative raw-material technologies and has established immunological detection, molecular-biology detection, and protein core-sheet inspection platforms. The reported 50 R&D engineers and continuing R&D investment further support an established innovation function.

Production capacityThe supplier reports more than 10 production lines, 50 quality-control staff, a one-month off-peak lead time, and broad diagnostic-product offerings. It also reports 90% export sales and access to Shanghai, Ningbo, and Shenzhen ports, although the stated peak-season fulfillment time of 6–12 months indicates substantial seasonal capacity constraints.

Client casesThe supplier states that its products have been sold in more than 100 countries and regions. A separate record identifies a THC urine-test product and one associated Vietnamese buyer, but it does not provide verifiable case details such as order scale, duration, performance results, or references.